Expression of killer inhibitory receptors on cytotoxic cells from HIV- 1-infected individuals

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 472-476

  Galiani, M D ^a   Aguado, E ^a   Tarazona, R ^a   Romero, P ^a   Molina, I ^b   Santamaria, M ^a   Solana, R ^a   Peña, José ^a,c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

CD94; Cytotoxic T lymphocytes; HIV 1 and NKG2; KIR; NK

Indexed keywords

CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; INTERLEUKIN 10; LYMPHOCYTE MEMBRANE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD94; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-10; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032997244     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00833.x     Document Type: Article

References (33)

1. Lewis DE, Tang DS, Adu-Oppong A, Schober W, Rodgers JR. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994; 153:412-20.
2. Blackboum DJ, Mackewicz C, Barker E, Levy JA. Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine. Res Immunol 1994; 145:653-8.
3. Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991; 87:1462-6.
4. Sirianni MC, Mezzaroma I, Aiuti F, Moretta A. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody. Eur J Immunol 1994; 24:1874-8.
5. Sirianni MC, Tagliaferri F, Aiuti F. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today 1990; 11:81-82.
6. Scott-Algara D, Vuillier F, Cayota A, Dighiero G. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells. Clin Exp Immunol 1992; 90:181-7.
7. Ratcliffe LT, Lukey PT, Mackenzie CR, Ress SR. Reduced NK activity correlates with active disease in HIV-patients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol 1994; 97:373-9.
8. Pantaleo G, Soudeyns H, Demarest JF et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 1997: 94:9848-53.
9. Jewett A, Cavalcanti M, Giorgi J, Bonavida B. Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. J Immunol 1997; 158:5492-500.
10. Cauda R, Goletti D, Lucia MB et al. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. Clin Immunol Immunopathol 1994; 70:198-205.
11. De Maria A, Ferraris A, Guastella M et al. Expression of HLA class 1-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc Natl Acad Sci USA 1997: 94:10285-8.
12. Biassoni R, Falco M, Cambiaggi A et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995; 182:605-9.
13. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181:1133-44.
14. Luque I, Solana R, Galiani MD et al. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur J Immunol 1996; 26:1974-7.
15. Mandelboim O, Reyburn HT, Sheu EG et al. The binding site of NK receptors on HLA-C molecules. Immunity 1997; 6:341-50.
16. Moretta L, Cicconc E, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994; 55:341-80.
17. Colonna M, Navarro F, Bellon T et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186:1809-18.
18. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391:795-9.
19. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998; 187:813-8.
20. Lee N, Llano M, Carretero M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998: 95:5199-204.
21. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C J Immunol 1997: 158:3603-9.
22. Carretero M, Cantoni C, Bellon T et al. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory, receptor for HLA class I molecules. Eur J Immunol 1997; 27:563-7.
23. Perez-Villar JJ, Carretero M, Navarro F et al. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 1996; 157:5367-74.
24. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997; 9:24-34.
25. Melder RJ, Balachandran R, Rinatdo CR, Gupta P, Whiteside TL, Herberman RB. Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells. AIDS Res Hum Retrovir 1990; 6:1011-5.
26. Borrego F, Pena J, Solana R. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur J Immunol 1993; 23:1039-43.
27. Garcia-Cozar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Pena J, Santamaria M. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 1996; 104:72-79.
28. Lopez-Botet M, Carretero M, Perez-Villar J, Bellon T, Llano M, Navarro F. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules. Immunol Res 1997; 16:175-85.
29. Mingari MC, Vitale C, Cantoni C et al. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 1997; 27:1374-80.
30. Mingari MC, Ponte M, Bertone S et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998; 95:1172-7.
31. Finnegan A, Roebuck KA, Nakai BE et al. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 1996; 156:841-51.
32. Bergamini A, Bolacchi F, Faggioli E et al. HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin Exp Immunol 1998; 112:105-11.
33. Masood R, Lunardi-Iskandar Y, Moudgil T et al. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun 1994; 202;374-83.